We are live on ! Find out more
IBBQ icon

Invesco NASDAQ Biotechnology ETF

19 hedge funds and large institutions have $6.61M invested in Invesco NASDAQ Biotechnology ETF in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

6% more funds holding

Funds holding: 1819 (+1)

4.38% less ownership

Funds ownership: 22.27%17.89% (-4.4%)

25% less capital invested

Capital invested by funds: $8.87M → $6.61M (-$2.25M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IBBQ Hedge Fund Activity: Q2 2025 in Review

19 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2025, worth a combined $6.61M — down 25% from $8.87M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new IBBQ positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Raffa Wealth Management, opening a new position worth an estimated $258K. The largest seller was Advisory Services Network, exiting entirely with an estimated $1.15M sold.

  • 19 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2025, up from 18 in Q1 2025.
  • Funds reported $6.61M of Invesco NASDAQ Biotechnology ETF stock for Q2 2025, down 25% quarter-over-quarter.
  • 6 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2025 and 5 closed out, a net change of +1 holder.
  • The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2025 was Raffa Wealth Management, an estimated $258K added.
  • The largest Invesco NASDAQ Biotechnology ETF seller in Q2 2025 was Advisory Services Network, an estimated $1.15M sold.

Based on aggregated 13F filings for Q2 2025.